RxDoctor Payments DataLook up a doctor →

Bob Souder, MD

Gastroenterology · Jackson, TNNPI 1316934664

Payments from drug & device makers

$531,319in general payments, 2019–2025

Across 698 payments — averaging $761.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$156K
  • Intercept Pharmaceuticals, Inc.$122K
  • Ironwood Pharmaceuticals, Inc$100K
  • AbbVie$64K
  • Takeda Pharmaceuticals U.S.A., Inc.$43K
  • Braintree Laboratories, Inc.$14K
  • plus $33K from 28 others

What the payments were for

  • Consulting fees$8,20042%
  • Speaking & faculty fees$1,7259%
  • Travel & lodging$1,1716%
  • Food & beverage$8,35243%
  • Education$740%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$531,319 in reported general payments places this provider in the 90th percentile of 336 gastroenterology providers in Tennessee.

See all gastroenterology providers in Tennessee

Medicare billing

Part B allowed, 2024
$30,967
Medicare patients
204
Services billed
453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin17$57,173
LinzessLinaclotide60$52,271
TrulancePlecanatide32$21,514
Dexlansoprazole DrDexlansoprazole58$13,434
Famotidine373$7,976
Omeprazole313$4,718
Cimetidine56$4,297
Esomeprazole Magnesium46$1,606
Pantoprazole Sodium146$1,462
Ondansetron Hcl16$162
Clonazepam11$128

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance$1,605$78,68749 claims
AbbVieLinzess$63,699$52,27160 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 336 gastroenterology providers in Tennessee.

Other gastroenterology in Jackson

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →